NKGen Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NKGen Biotech and buy or sell other stocks, ETFs, and their options commission-free!

About NKGN

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. 

CEO
Paul Y. Song
CEOPaul Y. Song
Employees
63
Employees63
Headquarters
Santa Ana, California
HeadquartersSanta Ana, California
Founded
2017
Founded2017
Employees
63
Employees63

NKGN Key Statistics

Market cap
6.91M
Market cap6.91M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
—
Dividend yield—
Average volume
54.57K
Average volume54.57K
High today
$0.1772
High today$0.1772
Low today
$0.1222
Low today$0.1222
Open price
$0.1228
Open price$0.1228
Volume
105.79K
Volume105.79K
52 Week high
$2.19
52 Week high$2.19
52 Week low
$0.0983
52 Week low$0.0983
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.